HMOs biosynthesis technology
The chassis microorganisms are used to carry out genetic engineering editing, editing and regulation of metabolic pathways, and efficient biosynthesis technology for the production of the main substances in HMOs (2'-FL, 3-FL, LNT, LNnT) is realized through strain screening, strain fermentation, purification, detection and other processes.
The company uses biotechnology + AI to drive synthetic biology intelligent manufacturing, and takes the lead in realizing the pilot scale-up of lactose N tetraose (LNT) and lactose N neotetraose (LNnT) in HMOs in China, and the product quality has reached the industry-leading standard.
